Miloš Brkušanin is an Assistant Professor at the Faculty of Biology, University of Belgrade, and a Research Associate in the field of human molecular genetics, with a particular focus on inherited neuromuscular disorders. For over a decade, his scientific research has been dedicated to spinal muscular atrophy (SMA). As part of his doctoral thesis, he improved the molecular diagnostic procedures used in Serbia for SMA diagnosis.
Dr. Brkušanin is the originator and initiator of newborn screening for SMA in Serbia. He led the Feasibility Study for neonatal screening for this condition and actively advocated for its inclusion in the national screening program, which he now oversees. His scientific work also includes the study of biomarkers that can assist in evaluating the effectiveness of innovative genetic therapies for SMA.
He is a regular participant in international expert meetings and conferences on SMA, and he shares his knowledge and experience with colleagues across Southeast Europe, helping them plan and implement screening programs for this disease.
As a lecturer at the University of Belgrade, he inspires young researchers and students, and he actively contributes to the popularization of science through seminars, workshops, and summer schools. His research and dedication to science embody a blend of innovation, commitment, and vision for improving the lives of those affected by SMA.